Lifeward, previously ReWalk Robotics, announced that Jeff Dykan, current Chairman of the Lifeward Board of Directors, will retire from his role and will not stand for reelection effective at the 2024 Annual Meeting of Shareholders. Joseph Turk, who has served on Lifeward’s Board since 2022, has been appointed as the incoming Chairman and will assume the role following the upcoming shareholder meeting. Under Dykan’s leadership, Lifeward , previously ReWalk Robotics, has thrived as it grew from an early-stage concept, attracted a management team to lead development, navigated regulatory clearances – including a De Novo approval with the FDA, conducted an IPO, established an exoskeleton coverage policy for U.S. Veterans under the VA, acquired AlterG to grow its portfolio, and most recently, established reimbursement for personal exoskeletons under Medicare. Lifeward is greatly appreciative of Mr. Dykan’s guidance and leadership throughout the Company’s history of pioneering the exoskeleton and physical rehabilitation industries
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on LFWD:
- Lifeward launches AlterG NEO Anti-Gravity Treadmill
- Lifeward Unveils Newest Addition to Its AlterG Anti-Gravity Product Line – Introducing AlterG NEO
- Lifeward initiated with a Buy at Lake Street
- Lifeward to Present at Sidoti Virtual Investor Conference on June 12
- Lifeward price target raised to $13 from $9 at H.C. Wainwright